Early Academic Pursuits
Mrs. Golnaz Atri Roozbahani embarked on her academic journey with a Bachelor’s degree in Cellular and Molecular Biology-Genetics from Shahid Chamran University of Ahvaz, Iran, where she graduated with distinction, achieving a GPA of 17.94/20.00 (3.9/4.00). Her passion for genetics led her to pursue a Master’s degree in Biology-Genetics at Shahid Beheshti University, Tehran, Iran, where she conducted groundbreaking research on single nucleotide polymorphism rs137853118 in spermatogenesis-associated 16 gene, which is linked to male infertility in the Iranian population. Her academic excellence was recognized when she was awarded a direct admission to the MSc program without the necessity of an entrance exam.
Professional Endeavors
Mrs. Roozbahani has built an impressive professional portfolio, demonstrating her expertise across both academic and industrial settings. Currently, she serves as a Lab Research Assistant at Jena University Hospital, Institute of Human Genetics, Germany, where she supervises bachelor and master students in molecular genetics research. Previously, she worked as an R&D Responsible at TBA Biomedical Company in Tehran, where she contributed to innovative biomedical advancements. Additionally, she has held various research assistant roles at Shahid Beheshti University of Medical Sciences and the Faculty of Life Sciences and Biotechnology, gaining extensive experience in molecular biology and genetics research.
Contributions and Research Focus
Mrs. Roozbahani’s doctoral research at Friedrich Schiller University Jena, Germany, under the supervision of Prof. Dr. rer. nat. Aria Baniahmad, is focused on the biochemical and functional analysis of the novel androgen receptor antagonist C28 in human prostate cancer cells. Her work is crucial in understanding prostate cancer treatment mechanisms, with potential applications in targeted therapies. In addition to cancer genetics, she has worked on tumor spheroids, chromatin immunoprecipitation, cellular senescence, and protein interactions, which are key areas in biomedical research.
Impact and Influence
Through her diverse roles in research and development, Mrs. Roozbahani has contributed significantly to cancer research, genetic studies, and biomedical innovations. Her findings are instrumental in shaping the future of prostate cancer treatment and have the potential to advance personalized medicine approaches. She has also mentored several graduate students, imparting her knowledge and fostering the next generation of scientists and researchers.
Academic Citations and Recognitions
Her academic dedication has been recognized with multiple awards, including the prestigious DAAD (German Academic Exchange Service) Scholarship for doctoral studies in Germany (2021-present). She also ranked among the top 2% of all applicants in the Nationwide University Entrance Exam in Iran, demonstrating her exceptional academic capabilities.
Technical Skills and Expertise
- Cancer Research Methods: Xenograft mouse model studies, tumor spheroid generation, chromatin immunoprecipitation, and flow cytometry
- Molecular Biology Techniques: DNA, RNA, and protein extraction, cell culture, PCR variations (PCR-RFLP, ARMS-PCR, qRT-PCR), immunofluorescence, Western blotting
- Data Analysis and Bioinformatics: BD Accuri, GraphPad, MEGA, BioEdit, SNP STAT, and Microsoft Office Suite
Her technical expertise extends to cloning, competent bacteria generation, and cell viability analysis, making her a well-rounded molecular biologist.
Teaching and Mentorship
In addition to her research, Mrs. Roozbahani has been actively involved in mentorship and training. She has supervised and guided undergraduate and postgraduate students, helping them develop expertise in molecular genetics and cancer research. Her ability to convey complex concepts in an accessible and engaging manner has made her a respected mentor among students.
Legacy and Future Contributions
With a strong foundation in molecular genetics, oncology research, and biomedical innovations, Mrs. Roozbahani is poised to make significant contributions to cancer research and genetic therapeutics. Her work on androgen receptor antagonists has the potential to revolutionize prostate cancer treatments, and her commitment to academic excellence, mentorship, and research innovation will continue to influence the field for years to come.